Lark Health’s Post

There has been a lot of buzz lately around weight loss drugs like Ozempic, what is covered in specialty pharmacy, financial and mental wellbeing and much more. If you're seeking answers or want to learn about 2024 compliance and regulatory changes, look no further! This great article highlights the trends and what's to come throughout the year. Check it out. #2024trends #2024healthtrends

Missed out on Noom's Webinar regarding GLP-1s and 2024 key predictions? BenefitsPRO has you covered! They wrapped up a nice summary on the predictions Linda Anegawa, MD, Dipl. ABOM, DNBPAS and Jordan Galante Hidalgo discussed + the impact it will have on employee benefits. https://lnkd.in/gxXZYmdE

𝐃𝐨 𝐲𝐨𝐮 𝐭𝐫𝐮𝐬𝐭 𝐭𝐡𝐚𝐭 𝐲𝐨𝐮𝐫 (𝐏𝐁𝐌) 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭 𝐌𝐚𝐧𝐚𝐠𝐞𝐫 𝐢𝐬 𝐝𝐨𝐢𝐧𝐠 𝐫𝐢𝐠𝐡𝐭 𝐛𝐲 𝐲𝐨𝐮? Here are a few questions to ask your PBM: Is there independent oversight through 100% claim review? Do they analyze the contract and confirm that all rebates are directed to you the employer (100% pass-through model)? The following article is an example of how wrong it can go. #CFO #CEO #HR

Missed out on Noom's Webinar regarding GLP-1s and 2024 key predictions? BenefitsPRO has you covered! They wrapped up a nice summary on the predictions Linda Anegawa, MD, Dipl. ABOM, DNBPAS and Jordan Galante Hidalgo discussed + the impact it will have on employee benefits. #glp1 #ozempic #wegovy #mounjaro #noom #aom https://lnkd.in/gxXZYmdE

Join Mike Stull and Madison (Evans) Connor, as they begin our 2024 PBM Sightline Series, with PBM Fundamentals. Attendees will gain insight into market forces impacting pharmacy trends, different PBM pricing models, strategies to manage specialty pharmacy and more. 📅: 2/27/2024 🕰️: 3:00PM - 4:00PM ET Learn more and register for the webinar below. #pbm #webinar #healthbenefits

Congratulations to all of the businesses that ranked in the 2024 Best Cannabis Companies To Work For programs! Employee feedback comprises 75% of each company’s score. In order to make the list, companies had to have an employee engagement score of at least 80%. Read more about how these cultivation business and dispensary leaders are motivating their teams and creating a place people feel driven to do their best work and grow with the organization. https://lnkd.in/gnj_gj8K

GLP-1 Class Drugs: To Cover or Not? GLP-1 class drugs, primarily used for the treatment of type 2 diabetes, are highly sought after, given their effectiveness in managing blood sugar levels and promoting weight loss. Coverage of these drugs has even been seen as a recruiting strategy, particularly for potential employees who may be managing diabetes. However, industry turnover rates may impact the employer’s return on investment. Register now for @OneDigital’s exclusive Transform & Engage to join this timely session from pharmacy consulting expert @Richard Lo who offers the latest perspectives and considerations for this revolutionary class of medications. Washington, D.C.: https://lnkd.in/edA4nbWN #weareonedigital #transformandengage #makeitmatter #bestworkbestlife #workplacewellbeing

As high-cost specialty claims continue to be a significant factor in plan sponsor's overall pharmacy spend, it's important to explore various strategies to manage these claims effectively. Our upcoming Specialty Management webinar will provide insight into the biosimilar pipeline and the pros/cons of popular strategies including specialty and clinical management carve-out, site-of-care administration, and more! Join Mike Stull, Matthew Harman, and Courtney Keefe, PharmD on March 27th to gain valuable knowledge to help manage your high-cost specialty claims! See the link below to learn more: #PBM #PharmacyBenefits

The rising popularity of weight loss drugs has employers covering them more and more. Learn what GLP-1 drugs are and how employers are navigating their coverage in employee benefit plans https://lnkd.in/gmjKryUp

#HRIcon2024 | With a focus on communication, adaptability, and collaboration, Mohammad Alfawazi, CHRO, Tabuk Pharmaceuticals Manufacturing Company fosters a team environment that thrives on innovation and shared goals. Find out more from his recent interview with Anushree Sharma.